THE CHALLENGES OF ADVERTISING AND CONSUMER NEEDS IN BUSINESS COMMUNICATION
Foreign Languages for Special Purposes · 2025
DOI: 10.46991/flsp.2025.25.134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foreign Languages for Special Purposes, 2025. Verfasst von Marianna Ohanyan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Today, the world is heavily influenced by advertisements. In business, advertising is a form of communication that persuades and motivates individuals to take specific actions. A well-planned advertising campaign is crucial for driving high-quality traffic to the website and generating leads. It is a strategy for convincing a buyer to purchase a product. When creating and developing plans, it is important to approach the process with innovative and unconventional thinking. Companies should have a strong promotional strategy to compete in a highly competitive market. Several factors influence the consumer's decision-making process. Marketing-dominated stimulus is one of the most important factors in persuading customers to make a purchase. Advertising significantly impacts consumer demand and the entire consumer decision-making process. In other words, advertising grabs people's attention, builds brand recognition, and sparks interest in the promoted goods. Therefore, understanding consumer needs and developing suitable advertising strategies will help refine and grow the business.
Zitieren
APA
Ohanyan, M. (2025). THE CHALLENGES OF ADVERTISING AND CONSUMER NEEDS IN BUSINESS COMMUNICATION. Foreign Languages for Special Purposes. https://doi.org/10.46991/flsp.2025.25.134
Vancouver
Ohanyan M. THE CHALLENGES OF ADVERTISING AND CONSUMER NEEDS IN BUSINESS COMMUNICATION. Foreign Languages for Special Purposes. 2025. doi:10.46991/flsp.2025.25.134
BibTeX
@article{Ohanyan2025,
author = {Ohanyan, Marianna},
title = {THE CHALLENGES OF ADVERTISING AND CONSUMER NEEDS IN BUSINESS COMMUNICATION},
journal = {Foreign Languages for Special Purposes},
year = {2025},
doi = {10.46991/flsp.2025.25.134}
}
EUVIMED